Genome-wide in situ exon capture for selective resequencing

Emily Hodges, Zhenyu Xuan, Vivekanand Balija, Melissa Kramer, Michael N. Molla, Steven W. Smith, Christina M. Middle, Matthew J. Rodesch, Thomas J. Albert, Gregory J. Hannon, W. Richard McCombie

Research output: Contribution to journalArticle

488 Citations (Scopus)

Abstract

Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-protein-coding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.

Original languageEnglish (US)
Pages (from-to)1522-1527
Number of pages6
JournalNature genetics
Volume39
Issue number12
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Human Genome
Exons
Genome
Proteins
Technology
Mutation

ASJC Scopus subject areas

  • Genetics

Cite this

Hodges, E., Xuan, Z., Balija, V., Kramer, M., Molla, M. N., Smith, S. W., ... McCombie, W. R. (2007). Genome-wide in situ exon capture for selective resequencing. Nature genetics, 39(12), 1522-1527. https://doi.org/10.1038/ng.2007.42

Genome-wide in situ exon capture for selective resequencing. / Hodges, Emily; Xuan, Zhenyu; Balija, Vivekanand; Kramer, Melissa; Molla, Michael N.; Smith, Steven W.; Middle, Christina M.; Rodesch, Matthew J.; Albert, Thomas J.; Hannon, Gregory J.; McCombie, W. Richard.

In: Nature genetics, Vol. 39, No. 12, 01.12.2007, p. 1522-1527.

Research output: Contribution to journalArticle

Hodges, E, Xuan, Z, Balija, V, Kramer, M, Molla, MN, Smith, SW, Middle, CM, Rodesch, MJ, Albert, TJ, Hannon, GJ & McCombie, WR 2007, 'Genome-wide in situ exon capture for selective resequencing', Nature genetics, vol. 39, no. 12, pp. 1522-1527. https://doi.org/10.1038/ng.2007.42
Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW et al. Genome-wide in situ exon capture for selective resequencing. Nature genetics. 2007 Dec 1;39(12):1522-1527. https://doi.org/10.1038/ng.2007.42
Hodges, Emily ; Xuan, Zhenyu ; Balija, Vivekanand ; Kramer, Melissa ; Molla, Michael N. ; Smith, Steven W. ; Middle, Christina M. ; Rodesch, Matthew J. ; Albert, Thomas J. ; Hannon, Gregory J. ; McCombie, W. Richard. / Genome-wide in situ exon capture for selective resequencing. In: Nature genetics. 2007 ; Vol. 39, No. 12. pp. 1522-1527.
@article{570789360d7a402690150b9cd7ae75d2,
title = "Genome-wide in situ exon capture for selective resequencing",
abstract = "Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98{\%} of the human genome is composed of repeats and intergenic or non-protein-coding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85{\%} of the captured fragments are associated with targeted regions and up to 98{\%} of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.",
author = "Emily Hodges and Zhenyu Xuan and Vivekanand Balija and Melissa Kramer and Molla, {Michael N.} and Smith, {Steven W.} and Middle, {Christina M.} and Rodesch, {Matthew J.} and Albert, {Thomas J.} and Hannon, {Gregory J.} and McCombie, {W. Richard}",
year = "2007",
month = "12",
day = "1",
doi = "10.1038/ng.2007.42",
language = "English (US)",
volume = "39",
pages = "1522--1527",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Genome-wide in situ exon capture for selective resequencing

AU - Hodges, Emily

AU - Xuan, Zhenyu

AU - Balija, Vivekanand

AU - Kramer, Melissa

AU - Molla, Michael N.

AU - Smith, Steven W.

AU - Middle, Christina M.

AU - Rodesch, Matthew J.

AU - Albert, Thomas J.

AU - Hannon, Gregory J.

AU - McCombie, W. Richard

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-protein-coding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.

AB - Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-protein-coding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.

UR - http://www.scopus.com/inward/record.url?scp=36549021060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549021060&partnerID=8YFLogxK

U2 - 10.1038/ng.2007.42

DO - 10.1038/ng.2007.42

M3 - Article

C2 - 17982454

AN - SCOPUS:36549021060

VL - 39

SP - 1522

EP - 1527

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 12

ER -